Mural Oncology PLC — Director's Dealing 2023

Dec 18, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Mural Oncology plc (MURA)
CIK: 0001971543
Period of Report: 2023-12-14

Reporting Person: Jackson Scott Thomas (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-12-14	Stock Option (right to buy)	$3.61	A	15021	Acquired	2033-12-13	Ordinary Shares (15021)	Direct

Footnotes

F1: This option was granted on December 14, 2023. This option shall vest over three years in twelve equal quarterly installments on each quarterly anniversary of October 31, 2023, subject to the reporting person's continued service with the Issuer.